Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS Week 96 results

被引：0

作者：

Swindells, S. ^{[1
]}

Lutz, T. ^{[2
]}

Van Zyl, L. ^{[3
]}

Porteiro, N. ^{[4
]}

Benn, P. ^{[5
]}

Huang, J. ^{[6
]}

Harrington, C. ^{[7
]}

Hove, K. ^{[8
]}

Ford, S. ^{[9
]}

Talarico, C. ^{[7
]}

Chounta, V. ^{[5
]}

Crauwels, H. ^{[10
]}

Van Solingen-Ristea, R. ^{[10
]}

Vanveggel, S. ^{[10
]}

Margolis, D. ^{[7
]}

Smith, K. ^{[7
]}

Vandermeulen, K. ^{[10
]}

Spreen, W. ^{[7
]}

机构：

[1] Univ Nebraska Med Ctr, Nebraska Med Ctr, Omaha, NE USA

[2] Infektiologikum, Frankfurt, Germany

[3] Syzygy Clin Res Serv, Pretoria, South Africa

[4] Fdn IDEAA, Buenos Aires, DF, Argentina

[5] ViiV Healthcare, Brentford, England

[6] GlaxoSmithKline, Mississauga, ON, Canada

[7] ViiV Healthcare, Res Triangle Pk, NC USA

[8] GlaxoSmithKline, London, England

[9] GlaxoSmithKline, Res Triangle Pk, NC USA

[10] Janssen Res & Dev, Beerse, Belgium

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2020年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P006

引用

页码：19 / 21

页数：3

共 50 条

[1] Cabotegravir plus rilpivirine long-acting as HIV-1 maintenance therapy: ATLAS week 96 results
Swindells, Susan
Lutz, Thomas
Van Zyl, Lelanie
Porteiro, Norma
Benn, Paul
Huang, Jenny O.
Harrington, Conn M.
Hove, Kai
Ford, Susan L.
Talarico, Christine L.
Chounta, Vasiliki
Crauwels, Herta
Van Solingen-Ristea, Rodica
Vanveggel, Simon
Margolis, David A.
Smith, Kimberly Y.
Vandermeulen, Kati
Spreen, William R.
Baum, Alexander
[J]. INFECTION, 2021, 49 (SUPPL 1) : S7 - S8
[2] Long-acting cabotegravir plus rilpivirine as maintenance therapy: ATLAS week-48 results
Margolis, D. A.
Swindells, S.
Andrade-Villanueva, J-F
Richmond, G. J.
Rizzardini, G.
Baumgarten, A.
Masia, M. D. M.
Latiff, G.
Pokrovsky, V.
Mrus, J. M.
Huang, J. O.
Hudson, K. J.
Smith, K. Y.
Williams, P.
Spreen, W. R.
[J]. HIV MEDICINE, 2019, 20 : 20 - 21
[3] Long-acting cabotegravir plus rilpivirine for HIV treatment: FLAIR week 96 results
Orkin, C.
Oka, S.
Philibert, P.
Brinson, C.
Bassa, A. C.
Gusev, D.
Degen, O.
Gonzalez Garcia, J.
D'Amico, R.
Dorey, D.
Griffith, S.
Margolis, D. A.
St Clair, M.
Williams, P.
Spreen, W. R.
[J]. HIV MEDICINE, 2020, 21 : 14 - 14
[4] Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
Swindells, Susan
Andrade-Villanueva, Jaime-Federico
Richmond, Gary J.
Rizzardini, Giuliano
Baumgarten, Axel
Masia, Mar
Latiff, Gulam
Pokrovsky, Vadim
Bredeek, Fritz
Smith, Graham
Cahn, Pedro
Kim, Yeon-Sook
Ford, Susan L.
Talarico, Christine L.
Patel, Parul
Chounta, Vasiliki
Crauwels, Herta
Parys, Wim
Vanveggel, Simon
Mrus, Joseph
Huang, Jenny
Harrington, Conn M.
Hudson, Krischan J.
Margolis, David A.
Smith, Kimberly Y.
Williams, Peter E.
Spreen, William R.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (12): : 1112 - 1123
[5] Patient views on long acting HIV treatment: Cabotegravir plus rilpivirine as maintenance therapy (ATLAS 48 week results)
Murray, M.
Antela, A.
Mills, A.
Chounta, V.
Huang, J.
Jaeger, H.
Khuong-Josses, M-A.
Hudson, K.
Spreen, W.
Williams, P.
Margolis, D. M.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 2 - 2
[6] Cabotegravir plus rilpivirine as long-acting maintenance therapy: LATTE-2 week 48 results
Margolis, D.
Podzamczer, D.
Stellbrink, H-J
Lutz, T.
Angel, J.
Richmond, G.
Clotet, B.
Gutierrez, F.
Sloan, L.
Griffith, S.
St Clair, M.
Dorey, D.
Ford, S.
Mrus, J.
Crauwels, H.
Smith, K.
Williams, P.
Spreen, W.
[J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
[7] Week 96 extension results of a Phase 3 study evaluating long-acting cabotegravir with rilpivirine for HIV-1 treatment
Swindells, Susan
Lutz, Thomas
Van Zyl, Lelanie
Porteiro, Norma
Stoll, Matthias
Mitha, Essack
Shon, Alyssa
Benn, Paul
Huang, Jenny O.
Harrington, Conn M.
Hove, Kai
Ford, Susan L.
Talarico, Christine L.
Chounta, Vasiliki
Crauwels, Herta
Van Solingen-Ristea, Rodica
Vanveggel, Simon
Margolis, David A.
Smith, Kimberly Y.
Vandermeulen, Kati
Spreen, William R.
[J]. AIDS, 2022, 36 (02) : 185 - 194
[8] Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
Rizzardini, Giuliano
Overton, Edgar T.
Orkin, Chloe
Swindells, Susan
Arasteh, Keikawus
Gorgolas Hernandez-Mora, Miguel
Pokrovsky, Vadim
Girard, Pierre-Marie
Oka, Shinichi
Andrade-Villanueva, Jaime F.
Richmond, Gary J.
Baumgarten, Axel
Masia, Mar
Latiff, Gulam
Griffith, Sandy
Harrington, Conn M.
Hudson, Krischan J.
St Clair, Marty
Talarico, Christine L.
Patel, Parul
Cutrell, Amy
Van Eygen, Veerle
D'Amico, Ronald
Mrus, Joseph M.
Wu, Sterling
Ford, Susan L.
Chow, Ken
Roberts, Jeremy
Wills, Angela
Walters, Nicola
Vanveggel, Simon
Van Solingen-Ristea, Rodica
Crauwels, Herta
Smith, Kimberly Y.
Spreen, William R.
Margolis, David A.
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 85 (04) : 498 - 506
[9] COST-EFFECTIVENESS OF LONG-ACTING CABOTEGRAVIR PLUS LONG-ACTING RILPIVIRINE FOR THE TREATMENT OF HIV-1 IN TAIWAN
Wen, Y. C.
Ou, H. T.
Tien, K.
Harrison, C.
Omonmhenle, D.
Turner, M.
Anderson, S. J.
Jacob, I
[J]. VALUE IN HEALTH, 2023, 26 (06) : S145 - S145
[10] Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study
Orkin, Chloe
Oka, Shinichi
Philibert, Patrick
Brinson, Cynthia
Bassa, Ayesha
Gusev, Denis
Degen, Olaf
Garcia, Juan Gonzalez
Morell, Enrique Bernal
Tan, Darrell H. S.
D'Amico, Ronald
Dorey, David
Griffith, Sandy
Thiagarajah, Shanker
St Clair, Marty
Van Solingen-Ristea, Rodica
Crauwels, Herta
Ford, Susan L.
Patel, Parul
Chounta, Vasiliki
Vanveggel, Simon
Cutrell, Amy
Van Eygen, Veerle
Vandermeulen, Kati
Margolis, David A.
Smith, Kimberly Y.
Spreen, William R.
[J]. LANCET HIV, 2021, 8 (04): : e185 - e196

← 1 2 3 4 5 →